Form 4 for NAUT Nautilus Biotechnology, Inc.
Accepted 2025-09-09 00:00:00 ET · period of report 2025-09-05 · accession 0001378830-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-09-09 | 2025-09-05+ | NAUT | Patel Sujal M | CEO, Pres, Sec, Dir, 10% | P - Purchase | $0.6742 | +200.0K | 10.34M | +2% | +$134.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-05 | P | A | 116,500 | $0.67 | 10,258,221 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 116,500 shares purchased in the price range of $0.6547 to $0.6899 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |
| 2 | Common | Common Stock | 2025-09-08 | P | A | 83,500 | $0.68 | 10,341,721 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 83,500 shares purchased in the price range of $0.6581 to $0.7145 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |